1427 5 Pill - yellow round
Generic Name: dapagliflozin
Pill with imprint 1427 5 is Yellow, Round and has been identified as Farxiga 5 mg. It is supplied by Bristol-Myers Squibb Company.
Farxiga is used in the treatment of Chronic Kidney Disease; Heart Failure; Diabetes, Type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1427 5
Farxiga
- Generic Name
- dapagliflozin
- Imprint
- 1427 5
- Strength
- 5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- SGLT-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- Inactive Ingredients
-
microcrystalline cellulose,
lactose anhydrous,
crospovidone,
silicon dioxide,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-1427 (Discontinued) | |
| 00310-6205 | AstraZeneca |
Related images for "1427 5"
More about Farxiga (dapagliflozin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (149)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: SGLT-2 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
